These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 26493086)

  • 1. HMGB1 as a Key Mediator of Immune Mechanisms in Ischemic Stroke.
    Singh V; Roth S; Veltkamp R; Liesz A
    Antioxid Redox Signal; 2016 Apr; 24(12):635-51. PubMed ID: 26493086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke.
    Richard SA; Sackey M; Su Z; Xu H
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo.
    Faraco G; Fossati S; Bianchi ME; Patrone M; Pedrazzi M; Sparatore B; Moroni F; Chiarugi A
    J Neurochem; 2007 Oct; 103(2):590-603. PubMed ID: 17666052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review: Therapeutic Targeting of HMGB1 in Stroke.
    Tian X; Liu C; Shu Z; Chen G
    Curr Drug Deliv; 2017 Sep; 14(6):785-790. PubMed ID: 27501713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hyperglycemia worsens ischemic stroke-induced brain damage via high mobility group box-1 in rats.
    Huang J; Liu B; Yang C; Chen H; Eunice D; Yuan Z
    Brain Res; 2013 Oct; 1535():148-55. PubMed ID: 24012767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular and cellular mechanisms underlying the sterile inflammation after ischemic stroke].
    Shichita T
    Nihon Yakurigaku Zasshi; 2018; 151(1):9-14. PubMed ID: 29321396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between plasma high-mobility group box-1 levels and clinical outcomes of ischemic stroke.
    Huang JM; Hu J; Chen N; Hu ML
    J Crit Care; 2013 Oct; 28(5):792-7. PubMed ID: 23137435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation.
    Lutz W; Stetkiewicz J
    Int J Occup Med Environ Health; 2004; 17(2):245-54. PubMed ID: 15387080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status and future prospects in HMGB1 and receptor researches].
    Takahashi H; Nishibori M
    Nihon Rinsho; 2016 Apr; 74(4):703-11. PubMed ID: 27333763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-mobility group box-1 as an autocrine trophic factor in white matter stroke.
    Choi JY; Cui Y; Chowdhury ST; Kim BG
    Proc Natl Acad Sci U S A; 2017 Jun; 114(25):E4987-E4995. PubMed ID: 28584116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of High Mobility Group Box 1 in Ischemic Stroke.
    Ye Y; Zeng Z; Jin T; Zhang H; Xiong X; Gu L
    Front Cell Neurosci; 2019; 13():127. PubMed ID: 31001089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Posttranslational Modifications of HMGB1 During Immune Responses.
    Tang Y; Zhao X; Antoine D; Xiao X; Wang H; Andersson U; Billiar TR; Tracey KJ; Lu B
    Antioxid Redox Signal; 2016 Apr; 24(12):620-34. PubMed ID: 26715031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of HMGB1 in Cardiovascular Biology: Danger Signals.
    Cai J; Wen J; Bauer E; Zhong H; Yuan H; Chen AF
    Antioxid Redox Signal; 2015 Dec; 23(17):1351-69. PubMed ID: 26066838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis.
    de Souza AW; Westra J; Limburg PC; Bijl M; Kallenberg CG
    Autoimmun Rev; 2012 Oct; 11(12):909-17. PubMed ID: 22495229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1.
    Shichita T; Ito M; Morita R; Komai K; Noguchi Y; Ooboshi H; Koshida R; Takahashi S; Kodama T; Yoshimura A
    Nat Med; 2017 Jun; 23(6):723-732. PubMed ID: 28394332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of high mobility group box-1 in ischemic injury and tissue regeneration.
    Biscetti F; Ghirlanda G; Flex A
    Curr Vasc Pharmacol; 2011 Nov; 9(6):677-81. PubMed ID: 21692740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral stroke injury: the role of cytokines and brain inflammation.
    Siniscalchi A; Gallelli L; Malferrari G; Pirritano D; Serra R; Santangelo E; De Sarro G
    J Basic Clin Physiol Pharmacol; 2014 May; 25(2):131-7. PubMed ID: 24515999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases.
    Voll RE; Urbonaviciute V; Herrmann M; Kalden JR
    Isr Med Assoc J; 2008 Jan; 10(1):26-8. PubMed ID: 18300566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1, angel or devil, in ischemic stroke.
    Gao B; Wang S; Li J; Han N; Ge H; Zhang G; Chang M
    Brain Behav; 2023 May; 13(5):e2987. PubMed ID: 37062906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-mobility group box 1 (HMGB1) protein: friend and foe.
    Ulloa L; Messmer D
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):189-201. PubMed ID: 16513409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.